Knowledge

Hydroxyethylrutoside

Source 📝

88: 180: 286:
Incandela, L; Belcaro, G; Renton, S; Desanctis, MT; Cesarone, MR; Bavera, P; Ippolito, E; Bucci, M; et al. (2002). "HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: A prospective, placebo-controlled, randomized trial".
352:
Gulati, OP; Nordmann, H; Aellig, A; Maignan, MF; McGinness, J (1985). "Protective effects of O-(beta-hydroxyethyl)-rutosides (HR) against adriamycin-induced toxicity in rats".
189:
Relvène (1967 French version), Venoruton (1962 Swiss version), and Paroven are mixtures of hydroxyethyl rutinosides. Hydroxyethylrutosides are used in the treatment of
98: 397: 231: 159: 131: 138: 756: 751: 390: 70:
Oxerutins are semisynthetic derivatives of plant constituents. Although they are closely related to the natural flavonoid
190: 145: 629: 127: 106: 243:
Frick, RW (2000). "Three treatments for chronic venous insufficiency: Escin, hydroxyethylrutoside, and Daflon".
383: 64: 614: 117: 102: 54: 469: 38: 624: 596: 152: 652: 312: 268: 201: 361: 340: 304: 260: 74:, hydroxyethylrutosides are not found in food. The only way to take them is in a supplement. 485: 296: 252: 454: 194: 586: 430: 406: 200:
Hydroxyethylrutosides have been used as an alternative to horse chestnut preparations (
329: 745: 464: 459: 449: 272: 556: 474: 444: 410: 316: 35: 197:. Oxerutins work by reducing leakage from the small blood vessels (capillaries). 721: 688: 619: 542: 509: 49: 300: 256: 726: 698: 581: 571: 524: 519: 504: 499: 419: 341:
The handbook of clinically tested herbal remedies, Volume 2 by Marilyn Barrett
212: 59: 703: 674: 494: 308: 264: 365: 514: 439: 42: 375: 693: 591: 567: 116:
if you can. Unsourced or poorly sourced material may be challenged and
17: 634: 205: 683: 71: 379: 81: 354:
Archives Internationales de Pharmacodynamie et de Thérapie
289:
Journal of Cardiovascular Pharmacology and Therapeutics
208:. Typical doses are in the order of 1,000 mg/day. 113: 712: 672: 665: 643: 605: 565: 555: 533: 483: 428: 418: 215:-induced toxicity have been investigated in rats. 112:Please review the contents of the section and 34:-beta-hydroxyethyl-rutosides, HR, or HER) are 391: 8: 669: 562: 425: 398: 384: 376: 211:Effects of hydroxyethylrutosides against 224: 607:sclerosing agents for local injection 7: 232:Oxerutins on healthlibrary.epnet.com 25: 178: 86: 114:add the appropriate references 1: 666:Capillary stabilising agents 191:chronic venous insufficiency 99:reliable medical references 773: 330:Paroven on netdoctor.co.uk 301:10.1177/107424840200700103 257:10.1177/000331970005100303 630:Sodium tetradecyl sulfate 105:or relies too heavily on 65:Tetrahydroxyethylrutoside 615:Monoethanolamine oleate 470:Fluocinolone acetonide 128:"Hydroxyethylrutoside" 55:Dihydroxyethylrutoside 28:Hydroxyethylrutosides 757:Flavonol rutinosides 752:Quercetin glycosides 625:Inverted sugar syrup 597:Pentosan polysulfate 45:. Examples include: 295:(Suppl 1): S7–S10. 653:Calcium dobesilate 739: 738: 735: 734: 661: 660: 582:Organo-heparinoid 551: 550: 486:local anesthetics 420:Antihemorrhoidals 193:and hypertensive 187: 186: 163: 16:(Redirected from 764: 670: 563: 426: 400: 393: 386: 377: 370: 369: 349: 343: 338: 332: 327: 321: 320: 283: 277: 276: 240: 234: 229: 182: 181: 173: 170: 164: 162: 121: 90: 89: 82: 21: 772: 771: 767: 766: 765: 763: 762: 761: 742: 741: 740: 731: 708: 657: 639: 601: 574:for topical use 547: 529: 479: 455:Fluorometholone 431:corticosteroids 422:for topical use 414: 407:Vasoprotectives 404: 374: 373: 351: 350: 346: 339: 335: 328: 324: 285: 284: 280: 242: 241: 237: 230: 226: 221: 195:microangiopathy 183: 179: 174: 168: 165: 122: 111: 107:primary sources 91: 87: 80: 78:Health benefits 23: 22: 15: 12: 11: 5: 770: 768: 760: 759: 754: 744: 743: 737: 736: 733: 732: 730: 729: 724: 718: 716: 710: 709: 707: 706: 701: 696: 691: 686: 680: 678: 667: 663: 662: 659: 658: 656: 655: 649: 647: 641: 640: 638: 637: 632: 627: 622: 617: 611: 609: 603: 602: 600: 599: 594: 589: 587:Sodium apolate 584: 578: 576: 560: 553: 552: 549: 548: 546: 545: 539: 537: 531: 530: 528: 527: 522: 517: 512: 507: 502: 497: 491: 489: 481: 480: 478: 477: 472: 467: 462: 457: 452: 447: 442: 440:Hydrocortisone 436: 434: 423: 416: 415: 405: 403: 402: 395: 388: 380: 372: 371: 344: 333: 322: 278: 251:(3): 197–205. 235: 223: 222: 220: 217: 185: 184: 177: 175: 94: 92: 85: 79: 76: 68: 67: 62: 57: 52: 24: 14: 13: 10: 9: 6: 4: 3: 2: 769: 758: 755: 753: 750: 749: 747: 728: 725: 723: 720: 719: 717: 715: 711: 705: 702: 700: 697: 695: 692: 690: 687: 685: 682: 681: 679: 677: 676: 675:bioflavonoids 671: 668: 664: 654: 651: 650: 648: 646: 642: 636: 633: 631: 628: 626: 623: 621: 618: 616: 613: 612: 610: 608: 604: 598: 595: 593: 590: 588: 585: 583: 580: 579: 577: 575: 573: 569: 564: 561: 558: 554: 544: 541: 540: 538: 536: 532: 526: 523: 521: 518: 516: 513: 511: 508: 506: 503: 501: 498: 496: 493: 492: 490: 488: 487: 482: 476: 473: 471: 468: 466: 465:Dexamethasone 463: 461: 460:Fluocortolone 458: 456: 453: 451: 450:Betamethasone 448: 446: 443: 441: 438: 437: 435: 433: 432: 427: 424: 421: 417: 412: 408: 401: 396: 394: 389: 387: 382: 381: 378: 367: 363: 360:(2): 323–34. 359: 355: 348: 345: 342: 337: 334: 331: 326: 323: 318: 314: 310: 306: 302: 298: 294: 290: 282: 279: 274: 270: 266: 262: 258: 254: 250: 246: 239: 236: 233: 228: 225: 218: 216: 214: 209: 207: 204:) containing 203: 198: 196: 192: 176: 172: 169:February 2019 161: 158: 154: 151: 147: 144: 140: 137: 133: 130: –  129: 125: 124:Find sources: 119: 115: 109: 108: 104: 100: 95:This section 93: 84: 83: 77: 75: 73: 66: 63: 61: 58: 56: 53: 51: 48: 47: 46: 44: 40: 37: 33: 29: 19: 713: 673: 644: 606: 566: 557:Antivaricose 534: 484: 475:Fluocinonide 445:Prednisolone 429: 357: 353: 347: 336: 325: 292: 288: 281: 248: 244: 238: 227: 210: 199: 188: 166: 156: 149: 142: 135: 123: 103:verification 96: 69: 36:hydroxyethyl 31: 30:(oxerutins, 27: 26: 722:Tribenoside 689:Monoxerutin 620:Polidocanol 572:heparinoids 543:Tribenoside 97:needs more 50:Monoxerutin 39:derivatives 746:Categories 727:Etamsylate 699:Troxerutin 525:Pramocaine 520:Oxetacaine 505:Benzocaine 500:Tetracaine 219:References 213:adriamycin 202:venostasin 139:newspapers 60:Troxerutin 704:Hidrosmin 510:Dibucaine 495:Lidocaine 245:Angiology 43:rutosides 684:Rutoside 568:heparins 515:Procaine 309:12011966 273:19421726 265:10744007 694:Diosmin 592:Heparin 559:therapy 366:4004421 317:9720685 153:scholar 118:removed 18:Paroven 635:Phenol 364:  315:  307:  271:  263:  206:aescin 155:  148:  141:  134:  126:  714:other 645:other 535:other 313:S2CID 269:S2CID 160:JSTOR 146:books 72:rutin 362:PMID 305:PMID 261:PMID 132:news 101:for 570:or 411:C05 358:273 297:doi 253:doi 41:of 748:: 356:. 311:. 303:. 291:. 267:. 259:. 249:51 247:. 120:. 413:) 409:( 399:e 392:t 385:v 368:. 319:. 299:: 293:7 275:. 255:: 171:) 167:( 157:· 150:· 143:· 136:· 110:. 32:O 20:)

Index

Paroven
hydroxyethyl
derivatives
rutosides
Monoxerutin
Dihydroxyethylrutoside
Troxerutin
Tetrahydroxyethylrutoside
rutin
reliable medical references
verification
primary sources
add the appropriate references
removed
"Hydroxyethylrutoside"
news
newspapers
books
scholar
JSTOR
chronic venous insufficiency
microangiopathy
venostasin
aescin
adriamycin
Oxerutins on healthlibrary.epnet.com
doi
10.1177/000331970005100303
PMID
10744007

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.